Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRK6 | P43250 | 7/20 | 0.36 |
| ▸ | TYMP | P19971 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | QPCT | Q16769 | 1/20 | 0.31 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27684957 | 0.83 | GRK6 (0.36) | GRK6TYMPLMNAKDM4EHPGD | |
| SCHEMBL916408 | 0.78 | MAPT (0.39) | GRK6TYMPLMNASMN1; SMN2MAPT | |
| SCHEMBL3480905 | 0.69 | — | — | |
| SCHEMBL916143 | 0.65 | LMNA (0.34) | GRK6TYMPLMNAMAPTMEN1 | |
| SCHEMBL18284832 | 0.63 | LMNA (0.59) | TYMPLMNAKDM4EHPGDSMN1; SMN2 | |
| SCHEMBL15776050 | 0.62 | MAPT (0.35) | TYMPLMNASMN1; SMN2MAPTMEN1 | |
| SCHEMBL3480908 | 0.58 | NPC1 (0.39) | KDM4EMAPTRAB9A | |
| SCHEMBL3480902 | 0.58 | — | — | |
| SCHEMBL10498212 | 0.57 | PDE7A (0.47) | LMNASMN1; SMN2MAPTMEN1KMT2A | |
| SCHEMBL28424716 | 0.57 | ERN1 (0.49) | KDM4ESMN1; SMN2MAPTKMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1803712-B1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2015-12-30 | — | — | EP | disclosed |
| US-7872036-B2 | 3-triazolylphenyl sulfide derivative and insecticide, miticide and nematicide containing it as an active ingredient | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20090076282-A1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO., LTD (JP) | 2009-03-19 | — | — | US | disclosed |
| EP-1803712-A1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076282-A1 | 3-TRIAZOLYLPHENYL SULFIDE DERIVATIVE AND INSECTICIDE/ACARICIDE/NEMATICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT | CBR3, CBS, AHCYL1 | GRK6 1618/4885TYMP 3851/4885LMNA 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.